Straits Times Index
3,394.21 +17.02 (+0.50%) Nikkei
27,382.56 +19.81 (+0.07%) Hang Seng
22,688.90 +122.12 (+0.54%) FTSE 100
7,765.15 +4.04 (+0.05%) BTC-USD
23,235.92 +146.44 (+0.63%) CMC Crypto 200
526.66 +9.65 (+1.87%)
Atai Life Sciences N.V. (ATAI)
After hours:
| Previous close | 1.8200 |
| Open | 1.8100 |
| Bid | 1.7700 x 2200 |
| Ask | 1.7900 x 1400 |
| Day's range | 1.7700 - 1.8400 |
| 52-week range | 1.4500 - 6.3200 |
| Volume | |
| Avg. volume | 1,479,988 |
| Market cap | 296.916M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.3990 |
| Earnings date | 10 Nov 2022 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 13.58 |
- Business Wire
Women in Psychedelics Announces atai as Platinum Sponsors
TORONTO, November 04, 2022--The Women in Psychedelics Network ("WIPN" or "Network"), a network of professionals from all corners of the psychedelic industry strengthening women’s voices and providing opportunities to move mental health solutions forward, today announced atai Life Sciences N.V. (NASDAQ: ATAI) ("atai"), a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders, as a platinum sponsor of the Network, through its philanthropic arm atai Im
- Motley Fool
New Regulations for Psychedelics? Here's What Investors Need to Know
If you love investing in businesses that are on the bleeding edge of biotechnology, psychedelics companies are right up your alley. Despite substantial cultural baggage and significant legal hurdles, psychedelic medicines are proving themselves to be highly effective at treating mental illnesses like depression and post-traumatic stress disorder (PTSD), and that means they're likely to be quite lucrative for the developers. On July 13, the Drug Enforcement Agency (DEA) said it was scheduling a public hearing for Aug. 22, so people would have a chance to comment on a proposed rule that would move five psychedelic compounds into the Schedule 1 category.
